Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 3, 1998, Pages 1189-1194

  Alvarez Salas, Luis M ^a   Cullinan, Amy E ^c   Siwkowski, Andrew ^b   Hampel, Arnold ^b   Dipaolo, Joseph A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NORTHERN ILLINOIS UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; COMPLEMENTARY RNA; MESSENGER RNA; RIBOZYME;

CELL IMMORTALIZATION; CONFERENCE PAPER; CONTROLLED STUDY; GENE DISRUPTION; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; KERATINOCYTE; NEWBORN; PRIORITY JOURNAL; RNA TRANSLATION; UTERINE CERVIX CARCINOMA; VIRUS GENE; WART VIRUS;

HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0032477870     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.3.1189     Document Type: Article

References (64)

1. DiPaolo, J. A., Popescu, N. C., Alvarez, L. & Woodworth, C. D. (1993) Crit. Rev. Oncog. 4, 337-360.
2. Zur Hausen, H. & de Villiers, E. M. (1994) Annu. Rev. Microbiol. 48, 427-447.
3. Schiffman, M. H. (1995) J. Natl. Cancer Inst. 87, 1345-1347.
4. Hawley-Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R. & Schiller, J. T. (1989) EMBO J. 8, 3905-3910.
5. Phelps, W. C., Yee, C. L., Munger, K. & Howley, P. M. (1988) Cell 53, 539-547.
6. Viallet, J., Liu, C., Emond, J. & Tsao, M. S. (1994) Exp. Cell Res. 212, 36-41.
7. Yokoyama, M., Tsutsumi, K., Pater, A. & Pater, M. M. (1994) Obstet. Gynecol. 83, 197-204.
8. Dyson, N., Howley, P. M., Munger, K. & Harlow, E. (1989) Science 243, 934-937.
9. Werness, B. A., Levine, A. J. & Howley. P. M. (1990) Science 248, 76-79.
10. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. (1990) Cell 63, 1129-1136.
11. Huibregtse, J. M., Scheffner, M. & Howley, P. M. (1991) EMBO J. 10, 4129-4135.
12. Hubbert, N. L., Sedman, S. A. & Schiller, J. T. (1992) J. Virol. 66, 6237-6241.
13. Zerfass, K., Schulze, A., Spitkovsky, D., Friedman, V., Henglein, B. & Jansen-Durr, P. (1995) J. Virol. 69, 6389-6399.
14. Munger, K., Werness, B. A., Dyson, N., Phelps, W. C., Harlow, E. & Howley. P. M. (1989) EMBO J. 8, 4099-4105.
15. Wu, E. W., Clemens, K. E., Heck, D. V. & Munger, K. (1993) J. Virol. 67, 2402-2407.
16. Walder, J. (1988) Genes Dev. 2, 502-504.
17. Cotten, M., Schaffner. G. & Birnstiel, M. L. (1989) Mol. Cell. Biol. 9, 4479-4487.
18. Cohen, J. S. (1991) Antisense. Res. Dev. 1, 191-193.
19. Calabretta, B. (1991) Cancer Res. 51, 4505-4510.
20. Persaud, S. J. & Jones, P. M. (1994) J. Mol. Endocrinol. 12, 127-130.
21. Anazodo, M. I., Wainberg, M. A., Friesen, A. D. & Wright, J. A. (1995) J. Virol. 69, 1794-1801.
22. Nichols, G. L. (1995) Antisense. Res. Dev. 5, 67-69.
23. Henry, S. P., Zuckerman, J. E., Rojko, J., Hall, W. C., Harman, R. J., Kitchen, D. & Crooke, S. T. (1997) Anti-Cancer Drug Des. 12, 1-14.
24. Henry, S. P., Grillone, L. R., Orr, J. L., Bruner, R. H. & Kornbrust, D. J. (1997) Toxicology 116, 77-88.
25. Steele, C., Cowsert, L. M. & Shillitoe, E. J. (1993) Cancer Res. 53, 2330-2337.
26. von Knebel Doeberitz, M. & Gissmann, L. (1987) Haematol. Bluttransfus. 31, 377-379.
27. Hamada, K., Sakaue, M., Alemany, R., Zhang, W. W., Horio, Y., Roth, J. A. & Mitchell, M. F. (1996) Gynecol. Oncol. 63, 219-227.
28. Cech, T. R. (1988) J. Am. Med. Assoc. 260, 3030-3034.
29. Ojwang, J. O., Hampel, A., Looney, D. J., Wong-Staal, F. & Rappaport, J. (1992) Proc. Natl. Acad. Sci. USA 89, 10802-10806.
30. Koizumi, M., Kamiya, H. & Ohtsuka, E. (1993) Biol. Pharm. Bull. 16, 879-883.
31. Efrat, S., Leiser, M., Wu, Y. J., Fusco-DeMane, D., Emran, O.A., Surana, M., Jetton, T. L., Magnuson, M. A., Weir, G. & Fleischer, N. (1994) Proc. Natl. Acad. Sci. USA 91, 2051-2055.
32. Cech, T. R. (1993) Gene 135, 33-36.
33. Kashani-Sabet, M. & Scanlon, K. J. (1995) Cancer Gene Ther. 2, 213-223.
34. Kiehntopf, M., Esquivel, E. L., Brach, M. A. & Herrmann, F. (1995) Lancet 345, 1027-1031.
35. Thompson, J. D., Macejak, D., Couture, L. & Stinchcomb, D. T. (1995) Nat. Med. 1, 277-278.
36. Chen, Z., Kamath, P., Zhang, S., Weil, M. M. & Shillitoe, E. J. (1995) Cancer Gene Ther. 2, 263-271.
37. Shillitoe, E. J., Kamath, P. & Chen, Z. (1994) Cancer Gene Ther. 1, 193-204.
38. He, Y. K., Lu, C. D. & Qi, G. R. (1993) FEBS Lett. 322, 21-24.
39. Chen, Z., Kamath, P., Zhang, S., St. John, L., Adler-Storthz, K. & Shillitoe, E. J. (1996) Cancer Gene Ther. 3, 18-23.
40. Prody, G. A., Bakos, J. T., Buzayan, J. M., Schneider, I. R. & Bruening, G. (1986) Science 321, 1577-1580.
41. Feldstein, P. A., Buzayan, J. M. & Bruening, G. (1989) Gene 82, 53-61.
42. Hampel, A. & Tritz, R. (1989) Biochemistry 28, 4929-4933.
43. Haseloff, J. & Gerlach, W. L. (1989) Gene 82, 43-52.
44. Hampel, A., Tritz, R., Hicks, M. & Cruz, P. (1990) Nucleic Acids Res. 18, 299-304.
45. Berzal-Herranz, A., Joseph, S., Chowrira, B. M., Butcher, S. E. & Burke, J. M. (1993) EMBO J. 12, 2567-2573.
46. Anderson, P., Monforte, J., Tritz, R., Nesbitt, S., Hearst, J. & Hampel, A. (1994) Nucleic Acids Res. 22, 1096-1100.
47. Yu, M., Poeschla, E., Yamada, O., DeGrandis, P., Leavitt, M. C., Heusch, M., Yees, J. K., Wong-Staal, F. & Hampel, A. (1995) Virology 206, 381-386.
48. Yu, M., Ojwang, J., Yamada, O., Hampel, A.. Rapapport, J., Looney, D. & Wong-Staal, F. (1993) Proc. Natl. Acad. Sci. USA 90, 6340-6344.
49. Pirisi, L., Yasumoto, S., Feller M., Doniger, J. & DiPaolo, J. A. (1987) J. Virol. 61, 1061-1066.
50. Alvarez-Salas, L. M., Velazquez, A., Lopez-Bayghen, E., Woodworth, C. D., Garrido, E., Gariglio, P. & DiPaolo, J. A. (1995) Cancer Lett. 91, 85-92.
51. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Lab. Press, Plainview, NY).
52. Alvarez-Salas, L. M., Wilczynski, S. P., Burger, R. A., Monk, B. J. & DiPaolo, J. A. (1995) Int. J. Oncol. 7, 261-266.
53. Siwkowski, A., Shippy, R. & Hampel, A. (1997) Biochemistry 36, 3930-3940.
54. Zhou, C., Bahner, I., Rossi, J. J. & Kohn, D. B. (1996) Antisense Nucleic Acid Drug Dev. 6, 17-24.
55. Slebos, R. J., Kessis, T. D., Chen, A. W., Han, S. M., Hedrick, L. & Cho, K. R. (1995) Virology 208, 111-120.
56. Yan, Y., Ouellette, M. M., Shay, J. W. & Wright, W. E. (1996) Mol. Biol. Cell 7, 975-983.
57. Liu, X. L., Han, S., Baluda, M. A. & Park, N. H. (1997) Oncogene 14, 2347-2353.
58. Rossi, J. J., Elkins, D., Taylor, N., Zaia, J., Sullivan, S. & Deshler, J. O. (1991) Antisense Res. Dev. 1, 285-288.
59. Rossi, J. J. & Sarver, N. (1992) Adv. Exp. Med. Biol. 312, 95-109.
60. Crisell, P., Thompson, S. & James, W. (1993) Nucleic Acids Res. 21, 5251-5255.
61. Yuyama, N., Ohkawa, J., Koguma, T., Shirai, M. & Taira, K. (1994) Nucleic Acids Res. 22, 5060-5067.
62. Yamada, O., Kraus, G., Luznik, L., Yu, M. & Wong-Staal, F. (1996) J. Virol. 70, 1596-1601.
63. Ohkawa, J., Yuyama, N., Takebe, Y., Nisikawa, S., Homann, M., Sczakiel, G. & Taira, K. (1993) Nucleic Acids Symp. Ser. 121-122.
64. Altschuler, M., Tritz, R. & Hampel, A. (1992) Gene 122, 85-90.